3.13
Akut Solunum Yetmezliği III: Hiperkapnik Solunum Yetmezliği
Hiperkapnik solunum yetmezliği, diğer adıyla Tip 2 ya da ventilatuar solunum yetmezliği, vücudun kan dolaşımından karbondioksiti (CO_2) etkili bir şek…
Tip 2 veya hiperkapnik solunum yetmezliği, artmış karbondioksit üretimi veya azalmış alveoler ventilasyon nedeniyle ortaya çıkar.
45 mmHg'yi aşan arteriyel karbondioksit veya PaCO2 ve 7.35'in altında bir pH ile karakterizedir.
Hiperkapnik solunum yetmezliğine neden olan durumlar dört grupta toplanabilir.
İlk olarak, astım ve kistik fibroz gibi hava yolu ve alveol anormallikleri, hava yolu tıkanıklığına veya hava sıkışmasına yol açabilir ve bu da yeterli tidal hacim için artan inspiratuar çaba gerektirir.
Solunum kası yorgunluğu ve sonunda ventilasyon yetmezliği ile sonuçlanır.
Daha sonra, opioid doz aşımı gibi merkezi sinir sistemi anormallikleri, beyin sapının karbondioksite duyarlılığını azaltarak solunum dürtüsünü baskılar ve bu da yüksek PaCO2 seviyelerine yol açar.
Ek olarak, yelken göğüs gibi göğüs duvarı anormallikleri, ağrı ve kaburga kırıklarından kaynaklanan mekanik kısıtlama nedeniyle akciğer ve diyafragma hareketini sınırlar.
Son olarak, Guillain-Barré sendromu gibi nöromüsküler hastalıklar solunum kası zayıflığına veya felce neden olabilir.
Solunum kasları tehlikeye girdiğinde, normal PaCO2 seviyelerini koruyamazlar ve bu da solunum yetmezliğine yol açar.
View the full transcript and gain access to JoVE Core videos
Q1: What defines Type 2 or hypercapnic respiratory failure?
Type 2 respiratory failure, also called hypercapnic or ventilatory failure, occurs when the body cannot effectively remove carbon dioxide. It is characterized by arterial CO2 pressure (PaCO2) exceeding 45 mmHg and blood pH below 7.35. This indicates ventilatory demand surpasses the body's supply, meaning the ventilation needed to maintain normal PaCO2 levels exceeds what respiratory muscles can achieve without fatigue.
Q2: How do airway and alveoli abnormalities cause hypercapnic respiratory failure?
Conditions like asthma and cystic fibrosis cause airway obstruction or air trapping, requiring increased inspiratory effort to achieve sufficient tidal volume. This heightened work of breathing leads to respiratory muscle fatigue and eventual ventilatory failure, preventing adequate carbon dioxide elimination and resulting in elevated PaCO2 levels.
Q3: Why do central nervous system problems contribute to hypercapnic respiratory failure?
Central nervous system abnormalities, such as opioid overdoses or brainstem injuries, suppress the breathing drive by reducing the brainstem's sensitivity to carbon dioxide. When the medulla, the respiratory control center, cannot correctly sense and respond to CO2 changes, the body fails to maintain adequate ventilation, leading to elevated PaCO2 and respiratory failure.
Q4: What role do neuromuscular disorders play in developing hypercapnic respiratory failure?
Neuromuscular diseases like Guillain-Barré syndrome cause respiratory muscle weakness or paralysis. When respiratory muscles are compromised, they cannot maintain normal PaCO2 levels or generate sufficient ventilatory force. This severely limits the body's ability to eliminate carbon dioxide, directly contributing to ventilatory failure and hypercapnia.
Q5: How do chest wall abnormalities impair ventilation and cause respiratory failure?
Chest wall abnormalities such as flail chest, severe obesity, or kyphoscoliosis restrict chest and diaphragm movement due to pain or mechanical restriction from rib fractures. These conditions impair normal lung expansion and adequate ventilation, drastically reducing ventilatory supply and compromising the body's ability to eliminate carbon dioxide effectively.
Q6: Can diabetic ketoacidosis lead to hypercapnic respiratory failure?
Yes. Diabetic ketoacidosis causes metabolic acidosis, triggering rapid, deep breathing (Kussmaul respirations) as a compensatory mechanism. However, if the body becomes exhausted or has an underlying lung condition, this compensation fails, resulting in carbon dioxide retention and hypercapnic respiratory failure requiring urgent medical attention.
Q7: What management approach is essential for hypercapnic respiratory failure?
Management requires close monitoring of respiratory symptoms and carbon dioxide levels, with prompt intervention when breathing difficulty increases. A comprehensive, multidisciplinary approach involving respiratory therapists, neurologists, and pulmonologists aims to treat the underlying cause, enhance ventilation, and provide mechanical ventilatory support when necessary to ensure adequate oxygenation and pneumonia nursing management and prevention.